表紙:炎症性腸疾患 (IBD) 治療市場 - 分析、シェア、動向、規模、予測:2020年~2026年
市場調査レポート
商品コード
941400

炎症性腸疾患 (IBD) 治療市場 - 分析、シェア、動向、規模、予測:2020年~2026年

Inflammatory Bowel Disease Treatment Market, By Type, By Route of Administration, By Distribution Channel, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 154 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.11円
炎症性腸疾患 (IBD) 治療市場 - 分析、シェア、動向、規模、予測:2020年~2026年
出版日: 2020年06月01日
発行: AnalystView Market Insights
ページ情報: 英文 154 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

炎症性腸疾患 (IBD) 治療市場は、2019年までに158億7000万米ドルに達し、2020年~2026年の予測期間中のCAGRで、4.1%の成長が予測されています。

当レポートでは、世界の炎症性腸疾患 (IBD) 治療市場について調査分析し、市場概要、市場力学、セグメント別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 炎症性腸疾患 (IBD) 治療市場の概要

  • 調査範囲
  • 前提条件と調査手法

第2章 エグゼクティブサマリー

第3章 炎症性腸疾患 (IBD) 治療の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 炎症性腸疾患 (IBD) 治療業界分析

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長見通しマッピング
  • 規制の枠組み分析
  • COVID-19の影響分析

第5章 炎症性腸疾患 (IBD) 治療市場情勢

  • 市場シェア分析
  • 主要イノベーター
  • 内訳データ:主要メーカー別

第6章 炎症性腸疾患 (IBD) 治療市場:投与経路別

  • 概要
  • 経口
  • 注射剤

第7章 炎症性腸疾患 (IBD) 治療市場:タイプ別

  • 概要
  • クローン病
  • 潰瘍性大腸炎
  • その他

第8章 炎症性腸疾患 (IBD) 治療市場:流通経路別

  • 概要
  • 小売薬局
  • 病院薬局
  • オンライン薬局

第9章 炎症性腸疾患 (IBD) 治療市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 主要ベンダー分析

  • Pfizer Inc.
  • AbbVie Inc.
  • Cosmo Pharmaceuticals
  • UCB S.A.
  • Innovate Biopharmaceuticals
  • Gilead Sciences
  • Celgene Corporation
  • Celltrion Healthcare Co., Ltd.
  • Johnson & Johnson Services Inc.
  • Takeda Pharmaceutical Company Limited

第11章 アナリストの見解

第12章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Inflammatory Bowel Disease (IBD) Treatment market: Route of Administration Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration 2015-2026 (USD Million)
  • TABLE Inflammatory Bowel Disease (IBD) Treatment market: Type Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Type 2015-2026 (USD Million)
  • TABLE Inflammatory Bowel Disease (IBD) Treatment market: Distribution Channel Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel 2015-2026 (USD Million)
  • TABLE Inflammatory Bowel Disease (IBD) Treatment market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Region 2015-2026 (USD Million)
  • TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Country, 2015-2026 (USD Million)
  • TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)
  • TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)
  • TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)

List of Figures

  • FIGURE Inflammatory Bowel Disease (IBD) Treatment market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Route of Administration segment market share analysis, 2019 & 2026
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Oral segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE 5-Aminosalicylic Acid segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Corticosteroids segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Janus Kinase (JAK) Inhibitors segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Injectable segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Tumor Necrosis Factor (TNF) Inhibitors segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Interleukin inhibitors segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Anti-integrin segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Type segment market share analysis, 2019 & 2026
  • FIGURE Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Chron's Disease segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Ulcerative Colitis segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2019 & 2026
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Retail Pharmacy segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospital Pharmacy segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Online Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE Europe Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE Latin America Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE North America Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE U.S. Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE Germany Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE India Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE Brazil Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
目次

REPORT HIGHLIGHT

Inflammatory Bowel Disease (IBD) Treatment market was valued at USD 15.87 billion by 2019, growing with 4.1% CAGR during the forecast period, 2020-2026

Market Dynamics

A rise in the number of drugs available in clinical tests, growing prevalence of inflammatory bowel disease (IBD), and rising government initiatives related to the analysis of the causes and effective novel drug developments are the major factors driving the growth of global IBD treatment market. In addition, the high prevalence of and growing occurrence of ulcerative colitis and Chron's disease are likely to create growth opportunities in the IBD treatment market in the projected timeframe. However, stringent drug regulatory policies and lack of treatment effectiveness are predicted to impede the market growth in the coming future.

TYPES TAKEAWAY

The Crohn's disease type segment accounted for the majority of share in 2019 and is expected to rise at an impressive growth rate during the forecast period. This growth is primarily owing to the growing prevalence of the condition. As per a published article in 2018 in Jobson Medical Information LLC, the occurrence of Chron's disease was found to be approximately 3.1 to 14.6 cases per 100,000 people each year and the incidence in the U.S. was around 201 cases per 100,000 adults. On the other hand, the ulcerative colitis segment is expected to grow at the fastest rate throughout the forecast majorly due to presence of strong pipeline for the treatment of ulcerative colitis.

Route of Distribution Takeaway

The injectables route of administration segment is considered to be the largest due to its efficacy. Additionally, the development of biosimilars such as Inflectra is likely to boost the segmental market growth. Along with injectables, the oral route segment is projected to be the fastest-growing market by 2030 owing to the presence of strong pipeline products. The ASAs sub-segment of the oral route of administration subjugated the market in 2019 and the AK inhibitors sub-segment is estimated to grow at the fastest pace during the period of forecast.

Distribution Channel Takeaway

By distribution channel, the hospital pharmacy segment including both out-patient and in-patient subjugated the market in 2018 and is predicted to grow exponentially throughout the forecast. This is majorly owing to the rising prevalence of ulcerative colitis and Crohn's disease coupled with a growing total number of hospitalizations all across the globe. On the other hand, the online pharmacy is predicted to be the fastest-growing segmental market by the end of 2030. The increasing demand and rising trend of online purchasing are contributing to the growth of online pharmacy segment. In addition, customers find online pharmacy beneficial due to the availability of various offers and discounts.

REGIONAL TAKEAWAY

Presently, the North America market for IBD treatment is playing a dominant role owing to the presence of major market players and sophisticated healthcare infrastructure. The region is expected to lead the market during the period of forecast due to rising prevalence of Chron's diseases & ulcerative colitis and the growing increasing geriatric population in the U.S. On the other hand, the Asia Pacific region is estimated to grow at the fastest pace by the end of 2030 due to increasing product approvals in this region.

Key players of the market include:

  • Pfizer Inc.
  • AbbVie Inc.
  • Cosmo Pharmaceuticals
  • UCB S.A.
  • Innovate Biopharmaceuticals
  • Gilead Sciences
  • Celgene Corporation
  • Celltrion Healthcare Co., Ltd.
  • Johnson & Johnson Services Inc.
  • Takeda Pharmaceutical Company Limited

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2015 to 2018
  • Base Year - 2019
  • Estimated Year - 2020
  • Projected Year - 2026

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • 5-Aminosalicylic Acid
  • Corticosteroids
  • Janus Kinase (JAK) Inhibitors
  • Others
  • Injectable
  • Tumor Necrosis Factor (TNF) Inhibitors
  • Interleukin inhibitors
  • Anti-integrin
  • Others

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY TYPE

  • Chron's Disease
  • Ulcerative Colitis
  • Others

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY DISTRIBUTION CHANNEL

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
  • Others

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA

TABLE OF CONTENT

1. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Route of Administration
    • 2.1.2. Market Snippet by Type
    • 2.1.3. Market Snippet by Distribution Channel
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET - BY ROUTE OF ADMINISTRATION

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Route of Administration, 2019 & 2026 (%)
  • 6.2. Oral
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.3. 5-Aminosalicylic Acid
      • 6.2.3.1. Overview
      • 6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.4. Corticosteroids
      • 6.2.4.1. Overview
      • 6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.5. Janus Kinase (JAK) Inhibitors
      • 6.2.5.1. Overview
      • 6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.6. Others
      • 6.2.6.1. Overview
      • 6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Injectable
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.3. Tumor Necrosis Factor (TNF) Inhibitors
      • 6.3.3.1. Overview
      • 6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.4. Interleukin inhibitors
      • 6.3.4.1. Overview
      • 6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.5. Anti-integrin
      • 6.3.5.1. Overview
      • 6.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.6. Others
      • 6.3.6.1. Overview
      • 6.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET - BY TYPE

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)
  • 7.2. Chron's Disease
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Ulcerative Colitis
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Others
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET - BY DISTRIBUTION CHANNEL

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2019 & 2026 (%)
  • 8.2. Retail Pharmacy
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Hospital Pharmacy
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Online Pharmacy
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET- BY GEOGRAPHY

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.2.6. North America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.2.7. U.S.
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.2.8. Canada
      • 9.2.8.1. Overview
      • 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.3.6. Europe Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.3.7. Germany
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.9. United Kingdom
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.10. France
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.11. Rest of Europe
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.11. Rest of APAC
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Pfizer Inc.
    • 10.1.1. Company Snapshot
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Strategic Initiatives
  • 10.2. AbbVie Inc.
  • 10.3. Cosmo Pharmaceuticals
  • 10.4. UCB S.A.
  • 10.5. Innovate Biopharmaceuticals
  • 10.6. Gilead Sciences
  • 10.7. Celgene Corporation
  • 10.8. Celltrion Healthcare Co., Ltd.
  • 10.9. Johnson & Johnson Services Inc.
  • 10.10. Takeda Pharmaceutical Company Limited

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us